Literature DB >> 316642

Regulation of ribonucleotide reductase activity and its possible exploitation in chemotherapy.

L Witt, T Yap, R L Blakley.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 316642     DOI： 10.1016/0065-2571(79)90012-8

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN： 0065-2571


× No keyword cloud information.
  3 in total

1.  Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.

Authors:  Anthony Kicic; Anita C G Chua; Erica Baker
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  The Eltrombopag antitumor effect on hepatocellular carcinoma.

Authors:  Tomohiro Kurokawa; Soichiro Murata; Yun-Wen Zheng; Kenichi Iwasaki; Keisuke Kohno; Kiyoshi Fukunaga; Nobuhiro Ohkohchi
Journal:  Int J Oncol       Date:  2015-09-23       Impact factor: 5.650

3.  Targeting the Large Subunit of Human Ribonucleotide Reductase for Cancer Chemotherapy.

Authors:  Sanath R Wijerathna; Md Faiz Ahmad; Hai Xu; James W Fairman; Andrew Zhang; Prem Singh Kaushal; Qun Wan; Jianying Kiser; Chris G Dealwis
Journal:  Pharmaceuticals (Basel)       Date:  2011-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.